| Course | PA 533 Obstetrics & Gynecology |
|---|---|
| Week | 7 |
| Paper type | Contraceptive comparison table |
| Length | About 620 words, 5 pages |
| Format | APA 7 student paper |
| School | Chamberlain University |
| Program | Master of Physician Assistant Studies (MPAS) |
| Updated | October 2026 |
Free sample paper for PA 533 Week 7
Contraceptive Comparison Table for L.M.: Six Methods With Perfect-Use and Typical-Use Failure Side by Side, Columns for Bleeding, Return to Fertility and Eligibility, Two Methods Ruled Out and the Levonorgestrel IUD Chosen
Student Name
Chamberlain University
PA 533: Obstetrics & Gynecology
Instructor Name
Month Day, Year
Contraceptive Comparison Table for L.M.: Six Methods With Perfect-Use and Typical-Use Failure Side by Side, Columns for Bleeding, Return to Fertility and Eligibility, Two Methods Ruled Out and the Levonorgestrel IUD Chosen
The Person Above the Grid
L.M., 35, two children, a 2.5 cm fibroid within the uterine wall on ultrasound, leaving the cavity's shape untouched, heavy menstrual bleeding with iron deficiency, migraines without aura twice a month, blood pressure 118/72, nonsmoker, takes sertraline. Wants no more children for at least three years and possibly ever; would like fewer and lighter periods.
The Grid
Table 1
Contraceptive Options for L.M.
| Method | Failure with perfect use (first year) | Failure with typical use (first year) | Effect on bleeding | Return to fertility | Eligibility for L.M. |
|---|---|---|---|---|---|
| Levonorgestrel IUD, 52 mg | 0.2% | 0.2% | Much lighter; many stop bleeding | Prompt on removal | Category 1 to 2; fibroid without cavity distortion acceptable |
| Copper IUD | 0.6% | 0.8% | Often heavier | Prompt | Not ideal: would worsen bleeding |
| Implant | 0.05% | 0.05% | Unpredictable | Prompt | Acceptable |
| Combined pill | 0.3% | 9% | Lighter, regular | Prompt | Category 2 with migraine without aura |
| Injection | 0.2% | 6% | Often stops | Delayed up to 10 months | Acceptable |
| Condoms | 2% | 18% | None | Immediate | Acceptable as backup |
Note. Note. Failure rates from Trussell (2011); eligibility categories from the 2024 U.S. Medical Eligibility Criteria (Nguyen et al., 2024). Category 1 means no restriction; category 2 means benefits generally outweigh risks.
Both Figures, Side by Side
The gap between perfect and typical use is information about the method, not a footnote. Methods that depend on daily or per-act use, the pill and condoms, show large gaps because real life interrupts them. Long-acting methods show almost none, because once placed they work without further action (Trussell, 2011).
Columns That Hold Still
Each row is held to an identical set of five columns, so the methods can be compared directly. A column that changes meaning between rows would make the comparison meaningless.
Ruled Out, With the Reason Kept
Copper IUD: highly effective but would likely make L.M.'s heavy bleeding worse, the opposite of one of L.M.'s goals.
Injection: effective and often stops bleeding, but return to fertility can be delayed, and L.M. has not ruled out another child; also associated with bone density loss with long use.
The reasons are kept in the table so that if L.M.'s goals change, the comparison can be reopened.
A Recommendation That Chooses
Levonorgestrel 52 mg IUD. It is among the most effective methods, works for up to eight years, reduces menstrual blood loss substantially, treats L.M.'s heavy bleeding and iron deficiency at the same time and is compatible with a fibroid that does not distort the cavity. The U.S. eligibility criteria place it in a category where benefits outweigh risks for L.M.'s conditions (Nguyen et al., 2024). Insertion booked for next week with an ibuprofen dose beforehand.
If the IUD Does Not Suit
If L.M. finds the IUD intolerable, the implant is the next option for contraception, with tranexamic acid for bleeding if needed; the combined pill remains possible given migraine without aura, though it would be second line because of the daily use it requires.
What L.M. Was Told
L.M. heard the typical-use figures and said the gap for the pill "explains why my sister got pregnant on it." L.M. chose the IUD and asked for written information on insertion pain and what to expect in the first months, which was given.
References
Nguyen, A. T., Curtis, K. M., Tepper, N. K., Kortsmit, K., Brittain, A. W., Snyder, E. M., Cohen, M. A., Zapata, L. B., Whiteman, M. K., Baker, C., Dethier, D., Garbarino, S., Gold, H., Halper, E., Kapp, N., Krishna, G., Meurice, M., Ramer, S., Rodenhizer, J., . . . Wright, S. (2024). U.S. medical eligibility criteria for contraceptive use, 2024. MMWR Recommendations and Reports, 73(4), 1-126. https://doi.org/10.15585/mmwr.rr7304a1
Trussell, J. (2011). Contraceptive failure in the United States. Contraception, 83(5), 397-404. https://doi.org/10.1016/j.contraception.2011.01.021
The Chamberlain PA 533 Week 7 instructions
For week seven you compare contraceptive methods in a table. Put the person's situation and goals above the grid. Give every row the same columns: effectiveness under perfect use and under typical use side by side, effect on bleeding, return to fertility and eligibility for this person under current criteria. Treat the gap between perfect and typical use as information about the method. Keep the columns consistent so the methods can be compared directly. Rule out methods with reasons, and keep those reasons in the record. Make a recommendation that chooses one method for this person and explain why. Name a fallback. Cite sources for failure rates and eligibility.
Inside the PA 533 Week 7 example
The person section summarizes L.M.'s age, two children, a fibroid that spares the cavity, heavy bleeding with iron deficiency, migraine without aura, sertraline and goals. Table 1 compares the levonorgestrel IUD, copper IUD, implant, combined pill, injection and condoms, with Trussell's failure figures and 2024 US MEC categories in a note. A section explains why methods dependent on daily or per-act use show large typical-use gaps. Another explains why columns must hold still. The copper IUD is ruled out because it worsens bleeding, and the injection because of delayed fertility return and bone effects, with reasons kept. The 52 mg levonorgestrel IUD is chosen for effectiveness, bleeding reduction and eligibility, citing Nguyen and colleagues. A fallback and L.M.'s reaction to the figures close the paper.
PA 533 Week 7 rubric: what full points look like
Marks on this table go first to consistent columns and both effectiveness figures. A table with only one failure rate, or columns that change between rows, scores lowest. The next test is whether the person above the grid shapes the comparison; a generic table not tied to the patient is marked down. Credit goes to treating the typical-use gap as information. Methods ruled out must keep their reasons. The recommendation must choose; tables that end without a choice lose significant credit. Eligibility categories should match current criteria for the patient's conditions. Sources for failure rates and eligibility should be cited correctly, and a fallback adds marks. A note under the table listing the sources of each column keeps the figures checkable.
PA 533 Week 7 help from the desk
Comparison tables often lose marks by listing method facts without connecting them to the patient. Give us your patient's conditions and goals, and the table prepared for them would place the person above the grid, give every method the same columns with both failure figures and apply current eligibility categories. Ruled-out methods keep their reasons, a single method is chosen with a fallback, and the patient's response is recorded. If your patient is postpartum, breastfeeding or has a clotting history, eligibility changes and the table follows. Check each eligibility category against the current criteria before relying on the table.
Get a PA-533 Week 7 example written to your instructions
Send the Week 7 case with the column set your section requires, and a custom comparison is built inside it and returned inside 24 to 48 hours. The first one is free. If a recommendation paragraph or a patient facing summary is marked alongside it, say so and both of them come back together.
More PA 533 papers and MPAS samples
- PA 533 Week 1: Prenatal Screening Claim Post
- PA 533 Week 2: Gestational Dating Exercise
- PA 533 Week 3: Physiologic Adaptation Write-Up
- PA 533 Week 4: Prenatal Visit Schedule Rationale
- PA 533 Week 5: Maternal-Fetal Risk Brief
- PA 533 Week 6: Abnormal Uterine Bleeding Workup
- PA 533 Week 8: Well-woman Visit Outline
- PA 532 Week 7: Postoperative Day Plan
- PA 531 Week 7: Disposition Decision Write-Up
- PA 530 Week 7: Return to Play Criteria
- PA 528 Week 7: Stroke Syndrome Correlation
PA 533 Week 7 questions, answered
Does the comparison have to include every method?
Follow the count your section asks for and pick the rest deliberately. A grid carrying everything in the catalog dilutes the comparison and pushes the reasoning off the page. Four to six options chosen because they are genuinely in play for this person, with a line explaining why the others are not, generally reads stronger than an exhaustive one.
Where should the numbers come from?
A published source, named in or under the grid, and the same source for every row. Mixing figures from several places produces rows that cannot be set against each other, which is the one thing this document has to do. If your section names a reference, use that one throughout even where you have seen different numbers elsewhere.
How much does the recommendation matter next to the grid?
More than the effort usually put into it. The grid demonstrates knowledge and the recommendation demonstrates judgment, and only one of those separates papers from each other. A closing paragraph pointing at particular cells, committing to an option and saying what would be reconsidered later is typically what lifts a mark.
Where can I find a free PA 533 Week 7 sample paper?
This page carries the full PA 533 Week 7 contraceptive table, six methods with perfect and typical use side by side and the levonorgestrel IUD chosen.
Why is the copper IUD ruled out in the PA 533 Week 7 sample?
It is highly effective but often makes periods heavier, the opposite of the patient's goal of lighter bleeding.